Issue 1/2014
Content (10 Articles)
Current Opinion
Evidence for the Use of Biological Therapies in Ulcers of the Foot in Diabetes
William J. Jeffcoate, Frances L. Game
Leading Article
Treg Vaccination in Autoimmune Type 1 Diabetes
Isabelle Serr, Benno Weigmann, Randi Kristina Franke, Carolin Daniel
Review Article
Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML)
Elisabetta Abruzzese, Massimo Breccia, Roberto Latagliata
Open Access
Review Article
Targeting Survivin in Cancer: Novel Drug Development Approaches
Bernd Groner, Astrid Weiss
Original Research Article
miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3
Lei Shi, Yi Wan, Guan Sun, Shuguang Zhang, Zhimin Wang, Yanjun Zeng
Original Research Article
Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France
Annaë Liu, Mélisande Bernard
Original Research Article
A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin
Houria Boulaiz, Antonia Aránega, Cáceres Blanca, Alvarez Pablo, Rodríguez-Serrano Fernando, Carrillo Esmeralda, Melguizo Consolación, Prados Jose
Adis Drug Evaluation
Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis
Sohita Dhillon
Adis Drug Evaluation
Bosutinib: A Review of Its Use in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
Yahiya Y. Syed, Paul L. McCormack, Greg L. Plosker
Erratum
Erratum to: A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin
Houria Boulaiz, Antonia Aránega, Blanca Cáceres, Pablo Alvarez, Fernando Serrano-Rodríguez, Esmeralda Carrillo, Consolación Melguizo, Jose Prados